Mandate

Vinge advises Irisity in connection with new issues

November 07, 2017 Capital Markets and Public M&A

Vinge is advising Irisity AB (publ), listed on Nasdaq First North, in connection with a rights issue and a directed new issue of shares.

The rights issue is underwritten to 100% through subscription undertakings and underwriting guarantees. The directed issue occurs via Vätterledens Invest and Hans Andersson & Co AB, both long term strategic investors. An extraordinary general meeting will adopt a resolution concerning the issues on 24 November and a prospectus is expected to be published on 5 December with the subscription period commencing on 7 December. Irisity conducts operations within intelligent camera surveillance and develops camera solutions with the help of proactive working and self learning algorithms.

Vinge’s team consists of Anders Strid, Frida Bäckegren, Joel Zetterström (IP) and corporate assistant Camilla Andersson.

Related

Vinge advises Fortinova Fastigheter AB (publ) on its first SEK 200 million green bond issue

Vinge has advised Fortinova Fastigheter AB (publ) (“Fortinova”) on the company’s first issue of senior unsecured green bonds in an aggregate principal amount of SEK 200 million, under a framework of up to SEK 600 million. Nordea, acted as sole bookrunner in connection with the bond issue.
September 18, 2026

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026